The proportion with at least 1 relapse of myelitis was greater in the AQP4-IgG seropositive NMOSD group (12 of 20, 60%) compared with the “double-seronegative” group (3 of 17, 18%; p = 0.019) (Table 1). The gene discussed is AQP4; the disease is myelitis.